The COVID-19 pandemic has caused economic disruption in many major segments of North America, Europe, and APAC regions. For healthcare M&A this has translated into the collapse of deals that were underway and limited options for companies in the healthcare M&A space. How can healthcare M&A recover from the business implications of the COVID-19 pandemic? Infiniti’s experts observed that the high dependency on healthcare is expected to cause a surge in valuations once the situation normalizes. With Infiniti’s M&A support solutions, healthcare companies can focus on finding the ideal deal shortly and gain data-driven guidance from our experts. To stay a step ahead of changing market dynamics, and tackle the impact of the COVID-19 crisis on healthcare M&A, request a free proposal.
This press release features multimedia. View the full release